The therapeutic specialties of osteoporosis in inflammatory rheumatic diseases has gained mounting interest in the last year. The paper describes special aspects of osteoporosis in rheumatoid arthritis, ankylosing spondylitis and systemic lupus erythematodes. The problems of glucocorticoid therapy are discussed intensively with regard to the recently published recommendations for glucocorticoid-induced osteoporosis. Risk factors of osteoporosis and the therapeutic implications are demonstrated intensively as well as the modifications of the recommendations.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1007/s00393-004-0572-9 | DOI Listing |
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!